Nutex Health is trading at $209.00, with a -5.05% move; broader market weakness is the likeliest context. - No fresh company-specific catalyst was found for September 28; the latest company news and analyst target updates predate the decline. - Reuters reported stocks fell as oil rose amid stalled U.S.-Iran talks, while Treasury yields pointed to rates staying higher. - Provided market data show major U.S. indexes lower, moving in the same direction as Nutex Health.